Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Diseases

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 33 articles:
HTML format
Text format



Single Articles


    March 2017
  1. WANG W, Lie P, Guo M, He J, et al
    Risk of hepatotoxicity in cancer patients Treated with immune checkpoint inhibitors: a systematic review and meta-analysis of published data.
    Int J Cancer. 2017 Mar 6. doi: 10.1002/ijc.30678.
    PubMed     Text format     Abstract available


    February 2017
  2. LI CH, Yen CH, Chen YF, Lee KJ, et al
    Characterization of the GNMT-HectH9-PREX2 Tripartite Relationship in the Pathogenesis of Hepatocellular Carcinoma.
    Int J Cancer. 2017 Feb 16. doi: 10.1002/ijc.30652.
    PubMed     Text format     Abstract available


    December 2016
  3. YANG X, Wu L, Lin J, Wang A, et al
    Distinct hepatitis B virus integration patterns in hepatocellular carcinoma and adjacent normal liver tissue.
    Int J Cancer. 2016 Dec 10. doi: 10.1002/ijc.30547.
    PubMed     Text format     Abstract available


  4. WU SM, Lin SL, Lee KY, Chuang HC, et al
    Hepatoma cell functions modulated by NEK2 are associated with liver cancer progression.
    Int J Cancer. 2016 Dec 7. doi: 10.1002/ijc.30559.
    PubMed     Text format     Abstract available


    November 2016
  5. MOHAMED NK, Hamad MA, Hafez MZ, Wooley KL, et al
    Nanomedicine in Management of Hepatocellular Carcinoma: Challenges and Opportunities.
    Int J Cancer. 2016 Nov 15. doi: 10.1002/ijc.30517.
    PubMed     Text format     Abstract available


  6. MANTHRAVADI S, Paleti S, Pandya P
    Impact of sustained viral response post curative therapy of hepatitis C-related hepatocellular carcinoma: A systematic review and meta-analysis.
    Int J Cancer. 2016 Nov 15. doi: 10.1002/ijc.30521.
    PubMed     Text format     Abstract available


  7. KIM G, Jang SY, Han E, Lee YH, et al
    Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study.
    Int J Cancer. 2016 Nov 7. doi: 10.1002/ijc.30506.
    PubMed     Text format     Abstract available


    August 2016
  8. KI KIM S, Ueda Y, Hatano E, Kakiuchi N, et al
    TERT promoter mutations and chromosome 8p loss are characteristic of nonalcoholic fatty liver disease-related hepatocellular carcinoma.
    Int J Cancer. 2016 Aug 11. doi: 10.1002/ijc.30379.
    PubMed     Text format     Abstract available


    June 2016
  9. XIE G, Wang X, Huang F, Zhao A, et al
    Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis.
    Int J Cancer. 2016 Jun 7. doi: 10.1002/ijc.30219.
    PubMed     Text format     Abstract available


  10. SAHLMAN P, Nissinen M, Pukkala E, Farkkila M, et al
    Cancer incidence among alcoholic liver disease patients in Finland: A retrospective registry study during years 1996-2013.
    Int J Cancer. 2016;138:2616-21.
    PubMed     Text format     Abstract available


    May 2016
  11. RAMESH V, Ganesan K
    Integrative functional genomic delineation of the cascades of transcriptional changes involved in hepatocellular carcinoma progression.
    Int J Cancer. 2016 May 19. doi: 10.1002/ijc.30195.
    PubMed     Text format     Abstract available


    April 2016
  12. AIZAWA K, Liu C, Tang S, Veeramachaneni S, et al
    Tobacco carcinogen (NNK) induces both lung cancer and non-alcoholic steatohepatitis and hepatocellular carcinomas in ferrets which can be attenuated by lycopene supplementation.
    Int J Cancer. 2016 Apr 26. doi: 10.1002/ijc.30161.
    PubMed     Text format     Abstract available


  13. WANG C, Zhang Y, Guo K, Wang N, et al
    Heat shock proteins in hepatocellular carcinoma: Molecular mechanism and therapeutic potential.
    Int J Cancer. 2016;138:1824-34.
    PubMed     Text format     Abstract available


  14. EEFSEN RL, Engelholm L, Willemoe GL, Van den Eynden GG, et al
    Microvessel density and endothelial cell proliferation levels in colorectal liver metastases from patients given neo-adjuvant cytotoxic chemotherapy and bevacizumab.
    Int J Cancer. 2016;138:1777-84.
    PubMed     Text format     Abstract available


  15. JU HL, Han KH, Lee JD, Ro SW, et al
    Transgenic mouse models generated by hydrodynamic transfection for genetic studies of liver cancer and preclinical testing of anti-cancer therapy.
    Int J Cancer. 2016;138:1601-8.
    PubMed     Text format     Abstract available


    March 2016
  16. ZIMMERMANN E, Berentzen TL, Gamborg M, Sorensen TI, et al
    Sex-specific associations between birth weight and adult primary liver cancer in a large cohort of Danish children.
    Int J Cancer. 2016;138:1410-5.
    PubMed     Text format     Abstract available


    January 2016
  17. GHOSH A, Ghosh A, Datta S, Dasgupta D, et al
    Hepatic miR-126 is a Potential Plasma Biomarker for Detection of Hepatitis B Virus Infected Hepatocellular Carcinoma.
    Int J Cancer. 2016 Jan 12. doi: 10.1002/ijc.29999.
    PubMed     Text format     Abstract available


  18. SUN L, Hu S, Yu L, Guo C, et al
    Serum Haptoglobin as a novel molecular biomarker predicting colorectal cancer hepatic metastasis.
    Int J Cancer. 2016 Jan 12. doi: 10.1002/ijc.29993.
    PubMed     Text format     Abstract available


    December 2015
  19. MCGLYNN KA, Hagberg K, Chen J, Braunlin M, et al
    Menopausal hormone therapy use and risk of primary liver cancer in the Clinical Practice Research Datalink.
    Int J Cancer. 2015 Dec 13. doi: 10.1002/ijc.29960.
    PubMed     Text format     Abstract available


    October 2015
  20. SCHMIDT B, Wei L, DePeralta DK, Hoshida Y, et al
    Molecular subclasses of hepatocellular carcinoma predict sensitivity to fibroblast growth factor receptor inhibition.
    Int J Cancer. 2015 Oct 20. doi: 10.1002/ijc.29893.
    PubMed     Text format     Abstract available


  21. IIO E, Ocho M, Togayachi A, Nojima M, et al
    A novel glycobiomarker, Wisteria floribunda agglutinin Macrophage Colony-Stimulating Factor Receptor, for predicting carcinogenesis of liver cirrhosis.
    Int J Cancer. 2015 Oct 5. doi: 10.1002/ijc.29880.
    PubMed     Text format     Abstract available


    September 2015
  22. TAKEUCHI S, Fukuda K, Arai S, Nanjo S, et al
    Organ-specific efficacy of HSP90 inhibitor in multiple-organ metastasis model of chemorefractory small cell lung cancer.
    Int J Cancer. 2015 Sep 17. doi: 10.1002/ijc.29858.
    PubMed     Text format     Abstract available


  23. LIAO YJ, Fang CC, Yen CH, Hsu SM, et al
    Niemann-Pick type C2 protein regulates liver cancer progression via modulating ERK1/2 pathway: Clinicopathological correlations and therapeutical implications.
    Int J Cancer. 2015;137:1341-51.
    PubMed     Text format     Abstract available


  24. LI MC, Chen PC, Tsai PC, Furue M, et al
    Mortality after exposure to polychlorinated biphenyls and polychlorinated dibenzofurans: a meta-analysis of two highly exposed cohorts.
    Int J Cancer. 2015;137:1427-32.
    PubMed     Text format     Abstract available


    August 2015
  25. XU X, Ling Q, Wang J, Xie H, et al
    Donor miR-196a-2 polymorphism is associated with hepatocellular carcinoma recurrence after liver transplantation in a Han Chinese population.
    Int J Cancer. 2015 Aug 27. doi: 10.1002/ijc.29821.
    PubMed     Text format     Abstract available


  26. WONG MC, Ching JY, Chan VC, Lam TY, et al
    Screening Strategies for Colorectal Cancer among Patients with Non-Alcoholic Fatty Liver Disease and Family History.
    Int J Cancer. 2015 Aug 20. doi: 10.1002/ijc.29809.
    PubMed     Text format     Abstract available


  27. HUNG CH, Hu TH, Lu SN, Kuo FY, et al
    Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus.
    Int J Cancer. 2015 Aug 11. doi: 10.1002/ijc.29802.
    PubMed     Text format     Abstract available


  28. STEPIEN M, Duarte-Salles T, Fedirko V, Floegel A, et al
    Alteration of Amino Acid and Biogenic Amine Metabolism in Hepatobiliary Cancers: Findings from a Prospective Cohort Study.
    Int J Cancer. 2015 Aug 3. doi: 10.1002/ijc.29718.
    PubMed     Text format     Abstract available


  29. CORREA D, Somoza RA, Lin P, Schiemann WP, et al
    Mesenchymal Stem Cells regulate Melanoma Cancer Cells extravasation to bone and liver at their perivascular niche.
    Int J Cancer. 2015 Aug 1. doi: 10.1002/ijc.29709.
    PubMed     Text format     Abstract available


    July 2015
  30. DENT BM, Ogle LF, O'Donnell RL, Hayes N, et al
    High-resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers.
    Int J Cancer. 2015 Jul 14. doi: 10.1002/ijc.29680.
    PubMed     Text format     Abstract available


  31. WU SM, Cheng WL, Liao CJ, Chi HC, et al
    Negative modulation of the epigenetic regulator, UHRF1, by thyroid hormone receptors suppresses liver cancer cell growth.
    Int J Cancer. 2015;137:37-49.
    PubMed     Text format     Abstract available


    June 2015
  32. DUARTE-SALLES T, Fedirko V, Stepien M, Aleksandrova K, et al
    Dietary Fat, Fat Subtypes and Hepatocellular Carcinoma in a Large European Cohort.
    Int J Cancer. 2015 Jun 16. doi: 10.1002/ijc.29643.
    PubMed     Text format     Abstract available


    May 2015
  33. HLEYHEL M, Belot A, Bouvier AM, Tattevin P, et al
    Trends in survival after cancer diagnosis among HIV-Infected Individuals between 1992 and 2009. Results from the FHDH-ANRS CO4 Cohort.
    Int J Cancer. 2015 May 14. doi: 10.1002/ijc.29603.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: